International Society of Surgery (ISS)

Société Internationale de Chirurgie (SIC)

Integrated Societies: IATSIC | IASMEN | BSI | ISDS

MINIMALLY INVASIVE ULTRASOUND-ASSISTED APPLICATION OF AG/CU NANOCOMPOSITES IN THE TREATMENT OF EXPERIMENTAL GENERALIZED PURULENT PERITONITIS CAUSED BY MULITDRUG-RESISTANT MIXED INFECTION petrmyronov@gmail.com

 
MINIMALLY INVASIVE ULTRASOUND-ASSISTED APPLICATION OF AG/CU NANOCOMPOSITES IN THE TREATMENT OF EXPERIMENTAL GENERALIZED PURULENT PERITONITIS CAUSED BY MULITDRUG-RESISTANT MIXED INFECTION
Author Details
6
Including the presenting author
Petro Myronov petrmyronov@gmail.com Sumy State University Department of Surgery, Traumatology, Orthopedics and Phthisiology Sumy Ukraine *
Igor Duzhyi duzhyi.igor@gmail.com Sumy State University Department of Surgery, Traumatology, Orthopedics and Phthisiology Sumy Ukraine
Tetiana Ivakhniuk t.ivakhnjuk@med.sumdu.edu.ua Sumy State University Department of Public Health Sumy Ukraine
Roman Pshenychnyi r.pshenychnyi@chem.sumdu.edu.ua Sumy State University Department of Theoretical and Applied Chemistry Sumy Ukraine
Volodymyr Bugaiov v.bugayov@med.sumdu.edu.ua Sumy State University Department of Surgery, Traumatology, Orthopedics and Phthisiology Sumy Ukraine
Viktoriia Holubnycha v.holubnichaya@med.sumdu.edu.ua Sumy State University Department of Public Health Sumy Ukraine
 
 
 
 
Petro Myronov
petrmyronov@gmail.com
Ukraine
Abstract
Oral or Poster
Generalized peritonitis is a severe complication that often results in death, especially in the presence of multidrug-resistant bacteria. The enhanced antibacterial properties of silver and copper as part of Ag/Cu nanocomposites (Ag/Cu NCs), combined with the physicochemical effects of low-frequency ultrasound (LFUS), can be an excellent pathogenetic basis for treating peritonitis. Aim: to investigate the effectiveness of using minimally invasive LFUS with Ag/Cu NCs in treating experimental generalized purulent peritonitis.
The experimental generalized purulent peritonitis was simulated on white rats using a mixture of multidrug-resistant Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. A 0.005% solution of Ag/Cu NCs with minimally invasive LFUS was used in the first group, and for control, a 0.05% Chlorhexidine solution was used in the second group. The effectiveness of treatment was assessed by morpho-histological and microbiological parameters, the presence of complications, mortality, and recovery times.
The combined application of minimally invasive LFUS with Ag/Cu NCs contributed to a more rapid elimination of purulent-inflammatory processes in the abdominal cavity (fig.1), reduction of bacterial contamination (fig.2), a decrease in the number of complications (15% in the first group; 60% in the second group), mortality (30% and 60% respectively), a reduction in the number of necessary planned sanitation (2.95±0.25 in the first group; 6.62±1.41 in the second group, p<0.05), and the timing of laparostomy closure (5.17±1.33 and 11.5±1.76 days respectively, p<0.05).
The application of minimally invasive LFUS with Ag/Cu NCs significantly reduces the healing time of experimental generalized purulent peritonitis, the number of complications, and the mortality rate.
https://storage.unitedwebnetwork.com/files/1258/43a5d1b91d9748cb99bd7a960a311aae.jpg
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
https://storage.unitedwebnetwork.com/files/1258/38a424e11e3db6430ddb0ed9c47ba49a.jpg
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
1 General Topics organized by ISS/SIC
1.03 General Surgery
Withdrawn
250
Abstract Prizes
No
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025